Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
iShares Bitcoin Trust
IBIT
|
+$844M |
| 2 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$807M |
| 3 |
Merck
MRK
|
+$531M |
| 4 |
CRH
CRH
|
+$462M |
| 5 |
Amazon
AMZN
|
+$431M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.54B |
| 2 |
Microsoft
MSFT
|
+$1B |
| 3 |
NVIDIA
NVDA
|
+$651M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$569M |
| 5 |
Micron Technology
MU
|
+$470M |
Sector Composition
| 1 | Technology | 17.02% |
| 2 | Healthcare | 13.82% |
| 3 | Financials | 11.94% |
| 4 | Industrials | 9.98% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Wave Life Sciences
WVE
$1.11B
| $10.1M | ﹤0.01% |
1,635,610
+1,121,029
| +218% | +$6.92M |
|
1402
nCino
NCNO
$3.48B
| $10.1M | ﹤0.01% |
269,790
+109,892
| +69% | +$4.11M |
|
1403
Krystal Biotech
KRYS
$4.16B
| $10.1M | ﹤0.01% |
56,635
+48,114
| +565% | +$8.56M |
|
1404
Arvinas
ARVN
$568M
| $10.1M | ﹤0.01% |
243,667
-115,146
| -32% | -$4.75M |
|
1405
Absci
ABSI
$381M
| $10.1M | ﹤0.01% |
1,769,994
+1,242,254
| +235% | +$7.06M |
|
1406
United Therapeutics
UTHR
$18.3B
| $10M | ﹤0.01% |
43,677
-75,532
| -63% | -$17.4M |
|
1407
Descartes Systems
DSGX
$8.96B
| $10M | ﹤0.01% |
109,619
-49,815
| -31% | -$4.56M |
|
1408
Life Time Group Holdings
LTH
$6.29B
| $10M | ﹤0.01% |
645,607
+459,998
| +248% | +$7.14M |
|
1409
Tractor Supply
TSCO
$32.1B
| $10M | ﹤0.01% |
191,390
+14,655
| +8% | +$767K |
|
1410
Prudential
PUK
$35.5B
| $10M | ﹤0.01% |
519,582
+433,857
| +506% | +$8.36M |
|
1411
Chart Industries
GTLS
$8.95B
| $10M | ﹤0.01% |
60,781
-56,711
| -48% | -$9.34M |
|
1412
Xponential Fitness
XPOF
$313M
| $10M | ﹤0.01% |
605,185
+165,164
| +38% | +$2.73M |
|
1413
iShares MSCI EAFE ETF
EFA
$67.1B
| $10M | ﹤0.01% |
125,222
-73,909
| -37% | -$5.9M |
|
1414
James River Group
JRVR
$244M
| $9.9M | ﹤0.01% |
1,064,757
-240,929
| -18% | -$2.24M |
|
1415
Dillards
DDS
$8.97B
| $9.89M | ﹤0.01% |
20,979
-74,805
| -78% | -$35.3M |
|
1416
Molina Healthcare
MOH
$9.8B
| $9.84M | ﹤0.01% |
23,954
+2,334
| +11% | +$959K |
|
1417
Blackrock
BLK
$174B
| $9.78M | ﹤0.01% |
11,730
-11,625
| -50% | -$9.69M |
|
1418
WD-40
WDFC
$2.86B
| $9.78M | ﹤0.01% |
38,595
-21,511
| -36% | -$5.45M |
|
1419
Solid Biosciences
SLDB
$420M
| $9.76M | ﹤0.01% |
+733,081
| New | +$9.76M |
|
1420
HealthStream
HSTM
$855M
| $9.76M | ﹤0.01% |
366,119
+120,430
| +49% | +$3.21M |
|
1421
PJT Partners
PJT
$4.47B
| $9.72M | ﹤0.01% |
103,093
-3,155
| -3% | -$297K |
|
1422
Edgewise Therapeutics
EWTX
$1.5B
| $9.71M | ﹤0.01% |
532,255
+400,900
| +305% | +$7.31M |
|
1423
TriMas Corp
TRS
$1.59B
| $9.7M | ﹤0.01% |
363,054
-5,696
| -2% | -$152K |
|
1424
WisdomTree
WT
$2.11B
| $9.68M | ﹤0.01% |
1,053,760
+250,356
| +31% | +$2.3M |
|
1425
WisdomTree India Earnings Fund ETF
EPI
$2.93B
| $9.68M | ﹤0.01% |
+222,303
| New | +$9.68M |
|